Search results

Kowa Pharmaceutical Europe AG is part of the Kowa Group, a global enterprise founded in 1894. Backed by over 130 years of innovation and expertise across pharmaceuticals, life sciences, trading, and manufacturing, we create value through quality, trust, and a worldwide network.

Memorises Bio is a therapeutic antibody discovery company spun out of Memo Therapeutics. We investigate human immune responses and translate them into therapeutic antibodies, combining deep repertoire capture with large-scale functional screening.

Xlife Sciences is a publicly listed life sciences incubator and accelerator. Xlife is focused on the value development and commercialization of promising research projects from universities and other research institutions. The goal is to bridge research and development to healthcare markets.

Based in Epalinges, Pilatus Biosciences focuses on developing a first-in-class antibody targeting metabolic checkpoints. The company is transforming cancer treatment by developing innovative therapies that strengthen the immune system to fight cancer.

Chemgineering Switzerland AG is a consulting and planning company with focus on the GxP-regulated environment. Consulting, concept studies, turnkey solutions – we offer the full range of services in pharma, biotech, fine chemicals, cosmetics, diagnostics, food and more.

Humans-in the Loop GmbH is an AI-native consultancy built for growing businesses navigating AI adoption. HITL was conceived from the ground up with AI-augmented delivery, an agentic operating team, and a compliance-first posture aligned to the EU AI Act and ISO 42001.

Zürich-based health technology company building clinical AI for European primary care. The Jupiter Ecosystem connects an EHR, a patient app and Dia, an AI clinical reasoning layer: AI proposes, the physician decides. ahtida’s live digital clinic is the proprietary data engine.

FIDAI is an AI data intelligence platform streamlining biotech due diligence. We help founders organize complex preclinical and clinical data into audit-ready data rooms, cutting investor review times from months to weeks and bridging the gap between scientific discovery and venture capital.

We bring the most sensitive biophysical assays to the high-throughput screening world. Our integrated biophysics platform combines lab automation with on-the-fly data analysis, allowing our customers to screen up to a million compounds within weeks, harnessing the power of direct binding assays.

Management consultancy dedicated to equipping life sciences organizations with clarity and foresight in strategy, execution, and innovation - we blend deep commercial industry expertise and scientific acumen with tools and frameworks from the behavioral sciences, design and systems thinking.

Step Pharma is a clinical stage precision oncology company. Dencatistat (STP938) is a first in class, oral, selective CTPS1 inhibitor currently in Phase I/II clinical development in essential thrombocythemia, biomarker selected solid tumours and relapsed/refractory lymphoma.

imunaris is a forward-thinking Swiss startup committed to facilitating commercial access for pharmaceuticals, medical devices, and diagnostics. With a focus on agile and efficient methods, we offer tailored solutions to conquer the complexities of the Swiss healthcare market.

nuantic offers AI-guided lead optimization to biotech and pharma customers developing protein- and peptide-based therapeutics. We're able to optimize affinity, developability and aspects of immunogenicity with outstanding success rates with 10x less effort as compared to traditional methods.

FoRx Therapeutics is a clinical-stage company that develops next-generation small molecule therapeutics targeting DNA Replication Stress pathways for anti-cancer therapy. The lead program is a highly potent and selective PARG inhibitor, FORX-428, which  moved into clinical Phase 1 in H2 2025.

arcoris bio develops next-generation technologies for biomarker detection in research and diagnostics. Its flagship MUSE platform provides universal, programmable signal amplification to enable highly sensitive and multiplex assays that drive the future of digital pathology.

Revnuu is an award-winning life-sciences and deep-tech marketing partner, delivering strategy and execution that turns pioneering science into market-ready, scalable organisations with lasting positive impact.  

Heidelberger & Partners helps life sciences firms turn compliance into a strategic advantage. They enable strong compliance and governance, confident decisions with a practical, business-focused approach, offering IPO readiness (non-financial compliance), board governance, and interim CCO support.

Humion is a Swiss cancer therapeutics biotech developing TCR-based T-cell therapies for solid tumors. We decode the immune responses of cancer super responders to identify validated tumor targerts and translate them into precise, patient-derived therapeutics.

Solvias is a Contract Research, Development & Manufacturing Organization We offer comprehensive, high quality and fast analytical services for small molecule API, biologics and cell & gene therapies, by ensuring the interplay of outstanding experts in every required individual discipline.

dEEGtal develops AI-driven solutions to enhance EEG analysis, starting with a medical device for epilepsy diagnosis. While focused on clinical applications, we are expanding to offer AI models that provide deeper insights into EEG data for neuroscience, pharma, and industry partners.

aevX Bio SA is a Swiss biotech start-up advancing a best-in-class long-acting local therapy for androgenetic alopecia, designed to maximize scalp efficacy while minimizing systemic exposure.

Provides services in business development, strategy and product evaluation.

ADM is a global leader in both human and animal nutrition. With industry-advancing innovations, a complete portfolio of ingredients and solutions to meet any taste, and a commitment to sustainability, we give customers an edge in solving the nutritional challenges of today and tomorrow.

We are a seed-stage biotech company dedicated to relentlessly pursuing functional cures for rare disease patients and their families. With an initial focus on rare diseases, we aim to expand our scope to include genetically defined common diseases in the future.

Jantar is a clinical R/D company in the field of chronic rhinosinusitis. Its asset is dicholine succinate for which clinical proof-of-concept has been established. DISU represents a differentiated new drug with strong safety, rapid efficacy and clear potential for global consumer health leadership.

We are a leading international company offering end-to-end solutions ranging from the automation, process engineering and validation of biotech and pharmaceutical plants. With more than two decades of experience in GMP environments, we have in-depth knowledge of the applicable regulations.  

At Labocare, our team is dedicated to ensuring the quality and reliability of your laboratory equipment through extensive experience and unwavering commitment. Our personnel includes certified service engineers and a management team with extensive years of experience in the industry.  

We offer state‑of‑the‑art, ready‑to‑use laboratories dedicated to research and scientific projects. Located close to office spaces, our ecosystem sits in the heart of Basel, one of Europe’s most dynamic scientific hubs.

PQE Group is a global service company specializing in biotech and life sciences. We provide services and to pharmaceutical and biotech companies. Operating in 23 countries with 1,900+ professionals and €101M revenue, we ensure patient safety through quality-driven services.

Hippocrates Research Swiss offers a boutique CRO model built on 30 years of experience. With a lean, agile structure and senior-level involvement, we transform scientific innovation into strong clinical assets, delivering capital efficiency, strategic focus, and measurable value.

Strategic Board & Transaction Advisory for Life Sciences Dr. Claudia Ulbrich advises growth-stage biotech and medtech companies as an independent board member and strategic advisor. She has more than 25 years experience as CEO, board member and advisor in private and public companies.

Business Strategy and Development Partner in the Life Science Industry with over 30 years of experience in Pharma, Pharma Chemistry and Biotech.  

Hemastatx brings innovation to patients with severe, underserved bleeding conditions. HMX-001 is a first-in-class anti-ADAMTS13 antibody targeting the root cause of severe bleeds in (rare) von Willebrand factor (VWF) disorders. Hemastatx is a KU Leuven spinoff and part of the BaseLaunch portfolio.

Preclinical stage biopharmaceutical company, spin off of the European Diabetes Study Center (CeeD), dedicated to developing first-in-class biotherapies against diabetes and metabolic diseases, harvesting the breakthrough potential of the muscle secretome to regulate metabolism, a novel and unexplored approach

Betta Scientific is a Life Sciences consultancy. We support start-ups and established companies in entering international markets. Our clients rely on us to design and execute global go-to-market strategies, build international distribution networks, and accelerate revenue generation across borders.

ACBio delivers marketing & communications strategies, content, and brand narratives to life science companies worldwide to help them gain market leadership. We blend PhD-level scientific knowledge with effective marketing tactics to translate complex tech into understandable value for stakeholders.

Biodelphis Therapeutics is a Swiss biotech startup, spinoff of EPFL. We developed a new generation of protease inhibitors with enhanced potency and safety, exhibiting all the qualities needed to become first-in-class drugs for the treatment of cancer, autoimmune diseases and bone diseases.

Enabling breakthrough medicines achieve the outcomes they were designed for. We unlock the full therapeutic potential of innovative drug candidates through our next-gen nanomedicine delivery platform. We want to establish our biovectors as the universal standard for targeted therapeutic delivery.

Alpinuity Bio aims to provide consulting services in the field of biopharmaceutical R&D specifically in translational science and biomarkers. We advise and support investors, start-ups and established companies in due diligence, scientific and technical aspects.

Clinical development strategy and execution, without noise.

Minaris is a global cell and gene therapy (CGT) CDMO and multimodal biosafety testing organization. With more than 25 years of CGT development and manufacturing expertise and more than 40 years in biosafety testing, Minaris combines deep legacy experience with state-of-the-art GMP facilities.

Accelsiors is a global, full-service clinical research organization delivering end-to-end trial solutions under one roof. For over 20 years, we’ve supported biopharma with scientific, regulatory, legal, and operational expertise, driving efficient, high-quality clinical development worldwide.

DKSH is a global distribution and strategic solutions partner for life science and industrial specialties. We provide innovative and sustainable pharmaceutical and biopharmaceutical ingredients to manufacturers across Asia, Europe, and North America.

Nucleus Network is a global early-phase clinical trial network supporting pharma and biotechs in Phase I and Ib development. We deliver FIH, SAD/MAD and PoC studies through integrated clinics in the UK (Hammersmith Medical Research), USA and Australia, with strong PK and translational expertise.

KennedyFitch is a partner-led collective specialised in Executive Search, People Advisory, and Leadership and Transformation. We work with organisations who want to create impact by building future-fit leadership, strong cultures, and people strategies that support sustainable performance.

Alp Bio AG is a Swiss biotech startup that combines human immune organoid technology with generative AI. The company provides immunogenicity intelligence to detect and mitigate anti-drug antibody (ADA) risks years before clinical trials, helping developers avoid costly late-stage failures.

Real Chemistry is a global healthcare communications network and partner to biotechs at every stage of commercialization, from early value creation to launch and beyond. Combining scientific expertise, data and AI‑driven insights, we help ideas break through scientifically and succeed commercially.

Hettich AG, based in Bäch, Switzerland, has supplied laboratory equipment since 1977. We develop and distribute Hettich instruments and represent Memmert, Helmer, B Medical Systems and delta T, supporting life science customers with expertise, reliability and local service.

RhyGaze is a cutting-edge biotechnology company based in Basel, Switzerland, and Philadelphia, Pa., USA, focused on developing gene therapies for retinal diseases causing blindness and aims to restore vision and transform the lives of patients worldwide.

We are a small CRO providing highly tailored services to customers with clinical trials and regulatory consulting needs. With expertise in drug, food supplements, medical devices, diagnostics and software, we support you at every stage of product's lifecycle, from preclinical development to market.

Headquartered in Switzerland with global operations, Space Peptides provides end-to-end pharmaceutical Peptide CRDMO services - covering discovery, process development, and GMP manufacturing. In addition, our portfolio comprises a broad range of generic Peptide APIs.

For >100 years, IMPAG has bridged the gap between global producers and the life science industry. As a GMP- and ISO-certified solution provider, we offer sustainable sourcing, expert application consulting, and a curated portfolio of specialty raw materials. Get in touch with us! Together unique!

Opterion Health AG is a privately owned, Swiss-based, clinical-stage biotech company developing innovative therapies for peritoneal dialysis (PD).

Pharmaron, founded in 2004, is a leading life sciences service provider offering research, development, and manufacturing across drug discovery and clinical development for small molecules, biologics, and CGT. With 22,000+ staff, it operates in China, the U.S., and the U.K.

Asemblis is a Swiss biotech company developing scalable, human-relevant in vitro models for obesity and metabolic disorders. The company partners with industry and research organizations to support translational R&D and decision-making in drug development.